These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15587002)

  • 1. Ethical aspects of substance abuse and intervention: reflecting on methadone maintenance in New Zealand.
    Kermack A
    N Z Bioeth J; 2001 Oct; 2(3):14-22. PubMed ID: 15587002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preventive ethics approach to methadone maintenance programmes.
    Townshend PL; Sellman JD; Coverdale JH
    N Z Bioeth J; 2001 Oct; 2(3):7-13. PubMed ID: 15587001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug czar seeks new emphasis on methadone treatment.
    AIDS Policy Law; 1997 Oct; 12(20):7. PubMed ID: 11364789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pro and contra: maintaining drug dependent patients on methadone].
    Sass H
    Nervenarzt; 1991 Sep; 62(9):521-3. PubMed ID: 1956470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [General practitioner views on drug-assisted rehabilitation and the Norwegian substance abuse reform].
    Aasland OG; Spilhaug G; Johannesen A
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):97-100. PubMed ID: 19151800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating primary care and methadone maintenance treatment: implementation issues.
    Herman M; Gourevitch MN
    J Addict Dis; 1997; 16(1):91-102. PubMed ID: 9046446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing ideologies in substance abuse treatment. Response.
    Wilson HJ
    N Z Bioeth J; 2001 Oct; 2(3):29-32. PubMed ID: 15587005
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid drugs in maintenance and detoxification treatment of opiate addiction; Substance Abuse and Mental Health Services Administration, HHS. Final rule.
    Fed Regist; 2001 Jan; 66(11):4076-102. PubMed ID: 11503765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical perspectives in caring for people living with addictions: The European experience.
    Uchtenhagen AA
    Int Rev Psychiatry; 2010; 22(3):274-80. PubMed ID: 20528657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriateness versus practicality of MMT. Response.
    Cape G
    N Z Bioeth J; 2001 Oct; 2(3):23-5. PubMed ID: 15587003
    [No Abstract]   [Full Text] [Related]  

  • 15. Methadone maintenance: past, present, and future.
    Renner JA
    Adv Alcohol Subst Abuse; 1983-1984 Fall-Winter; 3(1-2):75-90. PubMed ID: 6391105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A community pharmacist's perspective on the methadone maintenance programme. Response.
    Barron P
    N Z Bioeth J; 2001 Oct; 2(3):35-6. PubMed ID: 15587007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.